Aurodox
| Code | Size | Price |
|---|
| TAR-T30213-10mg | 10mg | £1,208.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Aurodox is a biochemical.
CAS:
12704-90-4
Formula:
C44H62N2O12
Molecular Weight:
810.982
Purity:
0.98
SMILES:
CC[C@H](C(=O)NCC=CC=C(/C)[C@@H](OC)[C@@H](C)[C@@H]1O[C@H](C=CC=CC=C(/C)C(=O)c2c(O)ccn(C)c2=O)[C@H](O)[C@@H]1O)[C@@]1(O)O[C@@H](C=CC=C/C)C(C)(C)[C@@H](O)[C@H]1O
References
1. Nie YL, Wu YD, Wang CX, Lin R, Xie Y, Fang DS, Jiang H, Lian YY. Structure elucidation and antitumour activity of a new macrolactam produced by marine-derived actinomycete Micromonospora sp. FIM05328. Nat Prod Res. 2017 Aug 20:1-6. doi: 10.1080/14786419.2017.1366479. [Epub ahead of print] PubMed PMID: 28823189.
2. Duncan MC, Wong WR, Dupzyk AJ, Bray WM, Linington RG, Auerbuch V. An NF-?B-based high-throughput screen identifies piericidins as inhibitors of the Yersinia pseudotuberculosis type III secretion system. Antimicrob Agents Chemother. 2014;58(2):1118-26. doi: 10.1128/AAC.02025-13. Epub 2013 Dec 2. Erratum in: Antimicrob Agents Chemother. 2016 Jul;60(7):4427. PubMed PMID: 24295981; PubMed Central PMCID: PMC3910828.
3. Kimura K, Iwatsuki M, Nagai T, Matsumoto A, Takahashi Y, Shiomi K, Omura S, Abe A. A small-molecule inhibitor of the bacterial type III secretion system protects against in vivo infection with Citrobacter rodentium. J Antibiot (Tokyo). 2011 Feb;64(2):197-203. doi: 10.1038/ja.2010.155. Epub 2010 Dec 8. PubMed PMID: 21139624.
4. Hogg T, Mesters JR, Hilgenfeld R. Inhibitory mechanisms of antibiotics targeting elongation factor Tu. Curr Protein Pept Sci. 2002 Feb;3(1):121-31. Review. PubMed PMID: 12370016.